Buradasınız

Anasayfa » Content

A REVIEW ON RECENT INNOVATION IN OSMOTICALLY CONTROLLED DRUG DELIVERY SYSTEM

Journal Name:

  • The International Journal of Pharmaceutical Research and Bio-Science

Publication Year:

  • 2012

Key Words:

Author Name
Abstract (2. Language): 
Conventional drug delivery systems have slight control over their drug release and almost control over the effective concentration at the target site. This kind of dosing pattern may result in constantly changing, unpredictable plasma concentrations. Drugs can be delivered in a controlled pattern over a long period of time by the controlled or modified release drug delivery systems. They include dosage forms for oral and transdermal administration as well as injectable and implantable systems. For most of drugs, oral route remains as the most acceptable route of administration. Certain molecules may have low oral bioavailability because of solubility or permeability limitations. Development of an extended release dosage form also requires reasonable absorption throughout the gastro-intestinal tract (GIT). Among the available techniques to improve the bioavailability of these drugs fabrication of osmotic drug delivery system is the most appropriate one. Osmotic drug delivery systems release the drug with the zero order kinetics which does not depend on the initial concentration and the physiological factors of GIT. This review brings out new technologies, fabrication and recent clinical research in osmotic drug delivery.
Bookmark/Search this post with
FULL TEXT (PDF): 
PDF icon arastirmax-review-recent-innovation-osmotically-controlled-drug-delivery-system.pdf
  • 3
  • English

REFERENCES

References: 

1.
Madhav
i BB, Nath AR, Banji D, Ramalingam R, Madhu MN and Kumar DS: Osmotic drug delivery system: a review. Pharmakine. 2009; 2: 5-14.
2.
Prescot
t LF: The need for improved drug delivery in clinical practice, in: Prescott LF, Nimmo WS (eds), Novel Drug Delivery and Its Therapeutic Application, John Wiley, UK, 1989: 1-11.
3.
Sastr
y SV, De Gennaro MD, Reddy IK and Khan MA: Atenolol gastrointestinal therapeutic system Part 1: Screening of
other chronic disease states. Besides oral osmotic delivery systems, implants that work on osmotic principles are promising for delivery of a wide variety of molecules with a precise rate over a long period of time. Further, with the discovery of newer and potent drugs by the biotechnology industry, the need to deliver such compounds at a precise rate certainly will pave the way for osmotic delivery systems to play an increasingly important role in drug delivery.
formulation variables. Drug Dev Ind Pharm 1997; 23: 2:157-165.
4. Mishra B,Makesh BK and Sankar C: Oral push-pull osmotic pumps of pentazocine hydrochloride: development and evaluation. Ind J Pharm Sci, 2006; 68:1:85-87.
5. Verma RK, Krishna DM and Garg S: Formulation aspects in the development of osmotically controlled oral drug delivery systems. J Control Release, 2002; 79:7-27.
6. YANG Xing-Gang, ZHANG Guo-Hua, LI Wei, PENG Bo, LIU Zhi-Dong and PAN Wei-San: Design and Evaluation of Jingzhiguanxin Monolithic Osmotic Pump Tablet. Chem Pharm Bull, 2006; 54: 4:465¬469.
7.
Makhij
a Sapna N and Vavia Pradeep R: Controlled porosity osmotic pump-based controlled release systems of pseudoephedrine I: Cellulose acetate as a semipermeable membrane. J Control Release, 2003; 89: 5-18.
8.
Srikond
a Sastry, Kotamraj Phanidhar and Barclay Brian: Osmotic controlled drug delivery system, in Li Xiaoling, Jasti Bhaskara R (eds), Design of Controlled Release Drug Delivery Systems, McGraw-Hill Companies, INC, New York 2006: 203¬229.
9. McClelland GA, Sulton SC, Engle K and
Zentner GM: The solubility-modulated osmotic pump: invitro / invivo release of diltiazem hydrochloride. Pharma Res 1991;
8:88-92.
10. Kaushal AM and Garg S: An update on osmotic drug delivery patents. Pharm Tech,
Aug 2003; 27: 38-44.
11. Bhatt PP: Osmotic drug delivery systems for poorly soluble drugs. The drug delivery companies report autumn/winter 2004.
12. Parmar NS, Vyas SK and Jain NK: Advances in controlled and novel drug delivery. CBS publisher & distributors, New
Delhi, pp 18-39, 2001.
13. Eckenhoff, Yum SI: The osmotic pump: novel research tool for optimizing drug regimen. Biomaterials, 1981; 2:89-97.
14. Higuchi T and Leeper HM: Improved osmotic dispenser employing magnesium sulfate and magnesium chloride. US Patent
3760804, 1973.
15. Higuchi T and Leeper HM: Osmotic dispenser with means for dispensing active agent responsive to osmotic gradient." US
Patent 3995631, 1976.
16. Theeuwes F: Elementary Osmotic Pump. J. Pharm. Sci., 1975, 64, 1987-1991.
17. Kaushal AM and Garg S: An update on osmotic drug delivery patents. Pharm. Tech.,
2003, 27, 38-44.
18. Good WR and Lee PI: Membrane-
controlled reservoir drug delivery systems, in Langer RS, Wise DL (eds), Medical Applications of Controlled Release, I Vol., Boca Raton, CRC Press; 1984: 1-39.
19. Theeuwes F and Higuchi T: Osmotic dispensing device with maximum and minimum sizes for the passageway. US
Patent 3916899, 1975.
20. Gaebler, F: Laser drilling enables advanced drug delivery systems. Coherent article for Pharm Manufacturing, Jan 2007;
1-7.
21. Theeuwes F, Saunders RJ and Mefford WS: Process for forming outlet passageways
in pills using a laser. US Patent 4088864; 1978.
22. Liu L and Wang X: Solubility modulated monolithic osmotic pump tablet for atenolol delivery. Eur J Pharm Biopharm 2008; 68: 2: 298-302.
23. Khanna, SC: Therapeutic system for sparingly soluble active ingredients. Ciba-Geigy Corporation, Ardsley, NY, US Patent 4992278, 1997.
24. Zentner GM, McClelland GA and
Sutton SC: Controlled porosity solubility-and resin-modulated osmotic drug delivery systems for release of diltiazem hydrochloride. J Control Release. 1991; 16:
1-2: 237-243.
25. Okimoto K, Ohike A and Ibuki R:
Design and evaluation of an osmotic pump tablet (OPT) for prednisolone: a poorly
ISSN: 2277-8713
1194 IJPRBS
water soluble drug using (SBE)7m-beta-CD.
Pharm Res, 1998; 15: 10:1562-1568.
26. Theeuwes F, Swanson DR and Guittard G: Osmotic delivery systems for the beta-adrenoceptor antagonists metoprolol and oxprenolol: Design and evaluation of systems for once-daily administration. Br J
Clin Pharmacol, 1985; 19: 2:69S-76S.
27. Santus G and Baker RW: Osmotic drug delivery: A review of the patent literature. J
Control Release, 1995; 35: 1:1-21.
28. Eckenhoff B, Theeuwes F and Urquhart J: Osmotically actuated dosage forms for rate-controlled drug delivery. Pharm
Technol 1987; 11: 96-105.
29. Jensen JL, Appel LE, Clair JH and Zentner GM: Variables that affect the mechanism of drug release from osmotic pumps coated with acrylate/methacrylate copolymer latexes. J Pharm Sci, 1995; 84:
5:530-533.
30. Vyas, S.P and Khar, R.K: Controlled
drug delivery: concept and advances. Vallabh prakashan, New Delhi, pp 477-501,
2001.
31. Suresh Vyas P, Prabakaran D, Paramjit Singh, Parijat Kanaujia, Jaganathan KS, Amith Rawat: Modified push-pull osmotic system for simultaneous delivery of Theophylline and Salbutamol: development and in vitro characterization. Int. J. Pharm.
2004; 284: 95-108.
32. Roger Rajewski A: Applicability of (SBE) 7m --CD in controlled-porosity osmotic pump tablets (OPTs). Int. J. Pharm.
2004; 286: 81-88.
33. Roger Rajewski A: Factors affecting membrane controlled drug release for an osmotic pump tablet utilizing (SBE)7m -¬CD as both a solubilizer and osmotic agent.
J. Control. Rel. 1999; 60: 311-319.
34. Giancarlo Santus, and Richard Baker W: Osmotic drug Delivery: a review of the patent literature. J Control. Rel. 1995; 35: 1¬21.
35. Kazuto Okimoto, Roger A. Rajewski, and Valentino J. Stella: Release of testosterone from an osmotic pump tablet utilizing (SBE)7m-P-cyclodextrin as both a solubilizing and an osmotic pump agent J.
Control. Rel. 1999; 58: 29-38.
36. Hai Bang Lee, Longxiao Liu, Jeong Ku, Gilson Khang, Bong Lee, John M. Rhee: Nifedipine controlled delivery sandwiched osmotic tablet system. J. Control. Rel. 2000;
68: 145-156.
37. Toshiaki Nagakura, Ken Ishihara, Toshiyuki Furukawa, Kohji Masuda, Takao Tsuda: Auto-regulated Osmotic pump for insulin therapy by sensing glucose concentration without energy supply.
Sensors and Actuators B. 1996; 34: 229-233.
38. Herbig SM., Cardinal J.R. and
Korsmeyer K.L., Smith KL: Asymmetric-membrane tablet coatings for osmotic drug
delivery. J. Control. Rel. 1995; 35: 127-136.
39. Mahalaxmi R, Phanidhar Sastri, Ravikumar, Atin Kalra, Pritam Kanagale and Narkhede. Enhancement of Dissolution of Glipizide from Controlled Porosity Osmotic Pump Using a Wicking Agent and a Solubilizing Agent. Int. J. Pharm Tech
Res. 2009; 1, (3): 705-711.
40. Pradeep Vavia R and Sapna Makhija N: Controlled porosity osmotic pump-based controlled release systems of pseudoephedrine 1. Cellulose acetate as semipermeable membrane. J. Control. Rel.
2003; 89; 5-18.
41. Ji-Eon Kim, Seung-Ryul Kim, Sun-Hee Lee, Chi-Ho Lee and Dae-Duk Kim: The effect of pore formers on the controlled release of cefadroxil from a polyurethane
matrix. Int. J. Pharm. 2000; 201: 29-36. 42. Sastry S, Kotamraj P and Barclay B: Osmotic controlled drug delivery system, in Li Xiaoling and Jasti Bhaskara R: Design of Controlled Release Drug Delivery Systems, McGraw-Hill Companies, INC, New York,
pp 203- 229,
43. Bonsen P, Place V, Heimlich K, Kwan KC,
Elementar
y Osmotic Pump for Indometacin. J. pharm, 2006.
44. Theeuwes F, Swanson D and Wong P: Sci., 1983; 72: 253- 258.
45. Liu L, Ku J, Khang G, Lee B, Rhee JM
and Lee HB. Nifedipine controlled delivery by sandwiched osmotic tablet system. J.
Cont. Rel., 2000; 68: 145-156.
46. Haslem J and Rork GS: Controlled porosity osmotic pump." US Patent 488063,
1989.
47. Thombrea AG, Cardinall JR, DeNoto A.R, Herbig S.M and Smith K.L:
Asymmetric membrane capsules for osmotic drug delivery: Development of a manufacturing process." J Cont. Rel., 1999;
57: 55-64.
48. Zentner GM, Rork GS and Himmelsteine KJ: Osmotic flow through controlled porosity films: an approach to
ISSN: 2277-8713
-194 IJPRBS
deliver water soluble compounds." J. Cont.
Rel., 1985; 2: 217-229.
49. Parmar NS, Vyas SK and Jain NK:
Advances in controlled and novel drug delivery. CBS publisher & distributors, New
Delhi, pp 18-39, 2001.
50. Theuwes, F, Wong PSL, Burkoth, TL,
Fox DA and Bicek PR: Colonic drug absorption and metabolism. Marcel Decker,
New York, 1993, pp 137-158.
51. Madhavi BB, Nath AR, Banji D,
Ramalingam R, Madhu MN and Kumar DS: Osmotic drug delivery system": a review. Pharmakinetics, dec 2009; 2:5-14.
52. Liu L, Ku J, Khang G, Lee B, Rhee JM
and Lee HB: Nifedipine controlled delivery by sandwiched osmotic tablet system." J.
Cont. Rel., 2000; 68: 145-156.
53. Conley R, Gupta SK and Satyan G: Clinical spectrum of the osmotic controlled release oral delivery system (OROS): an advanced oral delivery form. Current medical research and opinion 2006; 22:
1879-1892.
54. Arora S, Ali J, Ahuja A, Baboota S and
Qureshi J: Pulsatile drug delivery systems: An approach for controlled drug delivery."
Ind. J. Pharm. Sci., 2006; 68(3): 295-300.55. Malaterre V, Metz H, Ogorka J, Mader K, Gurny R and Loggia N: Influence of the hydration kinetics and the viscosity balance on the drug release performance of push-pull osmotic systems. Novartis Pharma AG, Technical R&D, Fabrikstrasse 2, CH-4056 Basel, Switzerland, 1-2.
56. Lee HB, Liu L, Ku J, Khang G, Lee B
and Rhee JM: Nifedipine controlled delivery sandwiched osmotic tablet system. J Control
Release, 2000; 68:145-156.
57. Choudhury PK, Ranawat MS, Pillai MK and Chauhan CS: Asymmetric membrane capsule for osmotic delivery of flurbiprofen.
Acta Pharm, 2007; 57:343- 350.
58. Liu L and Xu X: Preparation of bilayer-core osmotic pump tablet by coating the
indented core tablet. Int J Pham, 2008; 352:
1-2:225-230.
59. Philip AK
an
d Pathak K: In situ formed phase transited drug delivery system of ketoprofen for achieving osmotic controlled and level a in vitro in vivo correlation. Ind J
pharm Sci, 2008; 70: 6:745-753.
60. Mahalaxmi R, Sastri P, kumar R, Kalra A, Kanagale P and Narkhede: Enhancement of Dissolution of Glipizide from Controlled Porosity Osmotic Pump Using a Wicking
Agent and a Solubilizing Agent. Int J
PharmTech Res, 2009; 1: 3:705-711.
61. Kumar Pramod, Singh Sanjay and Mishra Brahmeshwar: Development and Evaluation of Elementary Osmotic Pump of Highly Water Soluble Drug: Tramadol Hydrochloride. Current Drug Delivery,
2009; 6:130-139.
62. Mothilal M, Damodharan N, Lakshmi
KS, Sharanya VB and Srikrishna T:
Formulatio
n and invitro evaluation of osmotic drug delivery system of metoprolol succinate. Int J Pharm Pharm Sci, 2010; 2:
2:64-68.
Available Online

Thank you for copying data from http://www.arastirmax.com